Harvard Bioscience
(HBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,048 | 4,255 | 4,283 | 5,340 | 4,324 |
| Receivables | 12,486 | 15,309 | 16,099 | 14,983 | 16,903 |
| Inventories | 25,130 | 24,136 | 24,716 | 25,818 | 26,089 |
| Other current assets | 4,766 | 4,448 | 3,940 | 4,345 | 5,301 |
| TOTAL | $46,430 | $48,148 | $49,038 | $50,486 | $52,617 |
| Non-Current Assets | |||||
| PPE Net | 4,758 | 4,492 | 3,981 | 3,358 | 3,491 |
| Intangibles | 70,068 | 71,377 | 73,101 | 73,317 | 75,127 |
| Other Non-Current Assets | 7,656 | 9,144 | 11,246 | 12,574 | 11,664 |
| TOTAL | $82,482 | $85,013 | $88,328 | $89,249 | $90,282 |
| Total Assets | $128,912 | $133,161 | $137,366 | $139,735 | $142,899 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,720 | 3,720 | 5,859 | 3,470 | 3,220 |
| Accounts payable and accrued liabilities | 5,711 | 6,044 | 5,554 | 6,269 | 4,716 |
| Other current liabilities | 13,190 | 14,716 | 15,129 | 8,336 | 9,046 |
| TOTAL | $22,621 | $25,677 | $26,542 | $24,205 | $22,942 |
| Non-Current Liabilities | |||||
| Long Term Debt | 31,960 | 31,890 | 30,704 | 35,273 | 38,203 |
| Deferred Revenues | N/A | N/A | N/A | 4,005 | 3,835 |
| Other Non-Current Liabilities | 6,320 | 6,010 | 6,270 | 5,310 | 5,699 |
| TOTAL | $39,044 | $38,672 | $37,750 | $41,244 | $44,569 |
| Total Liabilities | $61,665 | $64,349 | $64,292 | $65,449 | $67,511 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,611 | 43,430 | 43,399 | 42,688 | 42,688 |
| Common Shares | 436 | 434 | 434 | 457 | 457 |
| Retained earnings | -153,226 | -150,299 | -145,605 | -143,787 | -142,548 |
| Other shareholders' equity | -14,868 | -14,774 | -14,190 | -15,280 | -14,054 |
| TOTAL | $67,247 | $68,812 | $73,074 | $74,286 | $75,388 |
| Total Liabilities And Equity | $128,912 | $133,161 | $137,366 | $139,735 | $142,899 |